Faculty: Mark Emberton & Peter Carroll

Panel: Laurence Klotz & Herbert Lepor

Moderators: Andre Abreu & Tom Polascik


Dr. Mark Emberton

Mark Emberton is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London.  He is clinically active and holds the position of Honorary Consultant Urologist at University College London Hospitals NHS Trust where he works as a specialist in prostate cancer. 

His academic work has focused on developing novel diagnostic strategies and new therapies for men with prostate cancer.  His research has resulted in the transformation of both the diagnostic and therapeutic pathways.  These have been incorporated into international guidelines.

He has published over 400 peer review papers, holds a large grant portfolio, and lectures widely around the world and holds international honorary professorships.

He is a founding Pioneer of the charity Prostate Cancer UK. 

 

Dr. Peter Carroll

Dr. Peter Carroll is Professor of Urology and holds the Ken and Donna Derr-Chevron and Taube Family Distinguished Professorships at UCSF. He is a member of the UCSF Helen Diller Family Comprehensive Cancer Center and an expert in managing urologic cancers.

In research, Carroll’s areas of interest include innovative methods of urinary tract reconstruction, refinement of robotic prostatectomy, development of biomarkers that predict cancer aggressiveness, the use of active surveillance rather than immediate treatment for prostate cancer and how cancer detection and treatment impact quality of life. He has received many honors and awards, published more than 600 articles on cancer detection and treatment and is principal investigator or co-investigator of many peer-reviewed research grants.

Carroll graduated with honors from Georgetown University School of Medicine and came to UCSF for general surgery training and a residency in urology. He completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center before returning to UCSF. He received his MPH from the University of California at Berkeley

 

Dr. Herbert Lepor

Herbert Lepor, M.D. received his undergraduate degree from the University of California Los Angeles in 1975 and his doctor of medicine from The Johns Hopkins University School of Medicine in 1979.  Dr. Lepor completed his surgery and urology residency training at The Johns Hopkins Hospital. 

In 1993, Dr. Lepor was appointed Professor and Chairman of the Department of Urology, NYU Grossman School of Medicine and Professor of Pharmacology at NYU Grossman School of Medicine.  Dr Lepor is presently Chief Urologist at NYU Langone Medical Center and the “Martin Spatz Chairman of the Department of Urology” Dr. Lepor’s primary clinical and basic research interests are related to the prostate. 

Dr. Lepor  has served on the editorial boards for four major urological journals and has authored over 400 peer reviewed articles, 50 book chapters, and 12 books related to prostate cancer, benign prostatic hyperplasia, and the pharmacology of the prostate.  He is the co-founder and editor of Reviews in Urology.  Dr. Lepor has been a visiting professor at 30 institutions.  Some of Dr. Lepor’s landmark scientific contributions have focused on the identification of the autonomic intervention regulating male sexual function, development of the nerve sparing radical prostatectomy, improving outcomes following radical retro-pubic prostatectomy, outcomes following focal ablation of prostate cancer, characterization of the prostate alpha1 adrenoceptor, and the medical and surgical management of benign prostatic hyperplasia. 

In 1995, Dr. Lepor was awarded the Gold Cystoscope Award by The American Urological Association.  Dr. Lepor is a member of the American Association of Genitourinary Surgeons, Clinical Society of the American Association of Genitourinary Surgeons, the American Surgical Association, and the Johns Hopkins University Society of Scholars.

 

Dr. Andre Abreu

Assistant Professor of Clinical Urology and Radiology at the University of Southern California, Los Angeles – CA, USA.

Director of Image-guided Surgery and Focal Therapy of Prostate Cancer at USC.

He has expertise in minimally invasive and image-guided urologic surgery with focus on ablation therapy and robotic surgery for prostate cancer, and image-fusion prostate biopsy. He has published many articles in reputed peer-reviewed journals. He delivered several lectures nationally and internationally and presented numerous abstracts during the major Societies meetings, being granted with several awards.

 

Dr. Thomas J. Polascik

Thomas J. Polascik, MD FACS is Professor of Surgery, Duke University Medical Center.  He is the Director of Surgical Technology, Duke Prostate and Urological Cancer Center. He is the founder and co-director of the International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer that began at Duke in 2008. Dr Polascik is the Editor of the text Imaging and Focal Therapy of Early Prostate Cancer. He currently is the founder and President of the Focal Therapy Society, Duke’s Director of the Society of Urologic Oncology fellowship training program and the Genitourinary Program on Focal Therapy at the Duke Cancer Institute.  He is the Medical Director of Duke Men’s Health Initiative Screening event each September and is a governing member of several medical boards and societies.  His clinical and research interests focus on prostate and kidney cancer.  He has authored over 350 peer-reviewed manuscripts and book chapters.